Literature DB >> 24095926

Epithelial wounds induce differential phosphorylation changes in response to purinergic and EGF receptor activation.

Amanuel Kehasse1, Celeste B Rich2, Albert Lee2, Mark E McComb3, Catherine E Costello4, Vickery Trinkaus-Randall5.   

Abstract

Protein phosphorylation is a dynamic post-translational modification. Mass spectrometry-based quantitation was performed to determine the phosphoproteome profile of epithelial cells in response to injury, nucleotide, or epidermal growth factor. Phosphotyrosine enrichment used immunoprecipitation and immobilized metal affinity chromatography. Nucleotides released after scratch wounding activate purinergic receptors, leading to a distinct phosphorylation profile on epidermal growth factor receptor (EGFR) compared with its natural ligand. ATP induced a 2- to 15-fold phosphorylation increase over control on EGFR Y974, Y1086, and Y1148, with minimal phosphorylation intensity on EGFR Y1173 compared with the level measured in response to epidermal growth factor. Differential phosphorylation induced by epidermal growth factor or ATP was site specific on Src, Shc, phospholipase Cγ, protein kinase C, focal adhesion kinase, paxillin, and mitogen-activated protein kinases 1, 12, and 13. After wounding, the P2Y2 receptor mRNA expression increased, and after knockdown, migration and Ca(2+) mobilization were impaired. To examine phosphorylation mediated by P2Y2, cells were cultured in media containing stable isotope-labeled amino acids, the receptor was knocked down, and the cells were stimulated. Mass spectrometry-based comparison of the phosphorylation profiles of control versus transfected cells revealed a 50-fold decrease in phosphorylation of EGFR Y974 and 1086, with no decrease in Y1173 phosphorylation. A similarfold decrease in Src Y421 and Y446 and paxillin Y118 was detected, indicating the far-reaching importance of the P2Y2 receptor in mediating migration.
Copyright © 2013 American Society for Investigative Pathology. Published by Elsevier Inc. All rights reserved.

Entities:  

Mesh:

Substances:

Year:  2013        PMID: 24095926      PMCID: PMC5745543          DOI: 10.1016/j.ajpath.2013.08.015

Source DB:  PubMed          Journal:  Am J Pathol        ISSN: 0002-9440            Impact factor:   4.307


  32 in total

Review 1.  Purinergic signaling and vascular cell proliferation and death.

Authors:  Geoffrey Burnstock
Journal:  Arterioscler Thromb Vasc Biol       Date:  2002-03-01       Impact factor: 8.311

2.  P2Y receptors play a critical role in epithelial cell communication and migration.

Authors:  Veronica E Klepeis; Ilene Weinger; Elzbieta Kaczmarek; Vickery Trinkaus-Randall
Journal:  J Cell Biochem       Date:  2004-12-15       Impact factor: 4.429

3.  The P2Y2 receptor mediates the epithelial injury response and cell migration.

Authors:  Ilene Boucher; Celeste Rich; Albert Lee; Meredith Marcincin; Vickery Trinkaus-Randall
Journal:  Am J Physiol Cell Physiol       Date:  2010-04-28       Impact factor: 4.249

4.  A comparative study of electrostatic repulsion-hydrophilic interaction chromatography (ERLIC) versus SCX-IMAC-based methods for phosphopeptide isolation/enrichment.

Authors:  Chee Sian Gan; Tiannan Guo; Huoming Zhang; Sai Kiang Lim; Siu Kwan Sze
Journal:  J Proteome Res       Date:  2008-10-02       Impact factor: 4.466

5.  Targeted analysis of tyrosine phosphorylation by immuno-affinity enrichment of tyrosine phosphorylated peptides prior to mass spectrometric analysis.

Authors:  Adja D Zoumaro-Djayoon; Albert J R Heck; Javier Muñoz
Journal:  Methods       Date:  2011-09-16       Impact factor: 3.608

6.  Global, in vivo, and site-specific phosphorylation dynamics in signaling networks.

Authors:  Jesper V Olsen; Blagoy Blagoev; Florian Gnad; Boris Macek; Chanchal Kumar; Peter Mortensen; Matthias Mann
Journal:  Cell       Date:  2006-11-03       Impact factor: 41.582

7.  Injury and nucleotides induce phosphorylation of epidermal growth factor receptor: MMP and HB-EGF dependent pathway.

Authors:  Ilene Boucher; LingLing Yang; Courtney Mayo; Veronica Klepeis; Vickery Trinkaus-Randall
Journal:  Exp Eye Res       Date:  2007-03-31       Impact factor: 3.467

8.  Evidence for P2Y1, P2Y2, P2Y6 and atypical UTP-sensitive receptors coupled to rises in intracellular calcium in mouse cultured superior cervical ganglion neurons and glia.

Authors:  Jennifer A Calvert; Amelia E Atterbury-Thomas; Catherine Leon; Ian D Forsythe; Christian Gachet; Richard J Evans
Journal:  Br J Pharmacol       Date:  2004-10-04       Impact factor: 8.739

9.  Hierarchy of binding sites for Grb2 and Shc on the epidermal growth factor receptor.

Authors:  A G Batzer; D Rotin; J M Ureña; E Y Skolnik; J Schlessinger
Journal:  Mol Cell Biol       Date:  1994-08       Impact factor: 4.272

10.  Triple SILAC to determine stimulus specific interactions in the Wnt pathway.

Authors:  Maximiliane Hilger; Matthias Mann
Journal:  J Proteome Res       Date:  2011-11-18       Impact factor: 4.466

View more
  10 in total

1.  Purinoreceptor P2X7 Regulation of Ca(2+) Mobilization and Cytoskeletal Rearrangement Is Required for Corneal Reepithelialization after Injury.

Authors:  Martin S Minns; Gregory Teicher; Celeste B Rich; Vickery Trinkaus-Randall
Journal:  Am J Pathol       Date:  2015-12-10       Impact factor: 4.307

Review 2.  Purines in the eye: recent evidence for the physiological and pathological role of purines in the RPE, retinal neurons, astrocytes, Müller cells, lens, trabecular meshwork, cornea and lacrimal gland.

Authors:  Julie Sanderson; Darlene A Dartt; Vickery Trinkaus-Randall; Jesus Pintor; Mortimer M Civan; Nicholas A Delamere; Erica L Fletcher; Thomas E Salt; Antje Grosche; Claire H Mitchell
Journal:  Exp Eye Res       Date:  2014-08-20       Impact factor: 3.467

3.  P2Y2 nucleotide receptor activation enhances the aggregation and self-organization of dispersed salivary epithelial cells.

Authors:  Farid G El-Sayed; Jean M Camden; Lucas T Woods; Mahmoud G Khalafalla; Michael J Petris; Laurie Erb; Gary A Weisman
Journal:  Am J Physiol Cell Physiol       Date:  2014-04-23       Impact factor: 4.249

4.  A functional landscape of resistance to ALK inhibition in lung cancer.

Authors:  Frederick H Wilson; Cory M Johannessen; Federica Piccioni; Pablo Tamayo; Jong Wook Kim; Eliezer M Van Allen; Steven M Corsello; Marzia Capelletti; Antonio Calles; Mohit Butaney; Tanaz Sharifnia; Stacey B Gabriel; Jill P Mesirov; William C Hahn; Jeffrey A Engelman; Matthew Meyerson; David E Root; Pasi A Jänne; Levi A Garraway
Journal:  Cancer Cell       Date:  2015-03-09       Impact factor: 31.743

Review 5.  Purinergic Signalling: Therapeutic Developments.

Authors:  Geoffrey Burnstock
Journal:  Front Pharmacol       Date:  2017-09-25       Impact factor: 5.810

6.  Age Dependent Changes in Corneal Epithelial Cell Signaling.

Authors:  Kristen L Segars; Nicholas A Azzari; Stephanie Gomez; Cody Machen; Celeste B Rich; Vickery Trinkaus-Randall
Journal:  Front Cell Dev Biol       Date:  2022-05-05

7.  The NADPH Oxidases DUOX1 and NOX2 Play Distinct Roles in Redox Regulation of Epidermal Growth Factor Receptor Signaling.

Authors:  David E Heppner; Milena Hristova; Christopher M Dustin; Karamatullah Danyal; Aida Habibovic; Albert van der Vliet
Journal:  J Biol Chem       Date:  2016-09-20       Impact factor: 5.157

8.  The Role of Hypoxia in Corneal Extracellular Matrix Deposition and Cell Motility.

Authors:  Obianamma E Onochie; Anwuli J Onyejose; Celeste B Rich; Vickery Trinkaus-Randall
Journal:  Anat Rec (Hoboken)       Date:  2019-04-05       Impact factor: 2.064

Review 9.  Purinergic Signaling in Corneal Wound Healing: A Tale of 2 Receptors.

Authors:  Martin S Minns; Vickery Trinkaus-Randall
Journal:  J Ocul Pharmacol Ther       Date:  2016-09-19       Impact factor: 2.671

10.  Sustained Ca2+ mobilizations: A quantitative approach to predict their importance in cell-cell communication and wound healing.

Authors:  Yoonjoo Lee; Min Tae Kim; Garrett Rhodes; Kelsey Sack; Sung Jun Son; Celeste B Rich; Vijaya B Kolachalama; Christopher V Gabel; Vickery Trinkaus-Randall
Journal:  PLoS One       Date:  2019-04-24       Impact factor: 3.240

  10 in total

北京卡尤迪生物科技股份有限公司 © 2022-2023.